NIAID Banner Logo Image

HIV Citation List: March 28 - April 10, 2014

PubMed citations

1. A New Potential Approach to Block HIV-1 Replication via Protein-Protein Interaction and Strand-transfer Inhibition. Ferro, S., L. De Luca, G. Lo Surdo, F. Morreale, F. Christ, Z. Debyser, R. Gitto, and A. Chimirri. Bioorganic & Medicinal Chemistry, 2014. 22(7): p. 2269-2279. PMID[24618511].

[PubMed]. HIV_0328-041014.


2. Synthesis and Biological Evaluation of Novel Antiviral Agents as Protein-Protein Interaction Inhibitors. Ferro, S., L. De Luca, F. Morreale, F. Christ, Z. Debyser, R. Gitto, and A. Chimirri. Journal of Enzyme Inhibition and Medicinal Chemistry, 2014. 29(2): p. 237-242. PMID[23859152].

[PubMed]. HIV_0328-041014.


3. Ruxolitinib and Tofacitinib are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation in Vitro. Gavegnano, C., M. Detorio, C. Montero, A. Bosque, V. Planelles, and R.F. Schinazi. Antimicrobial Agents and Chemotherapy, 2014. 58(4): p. 1977-1986. PMID[24419350].

[PubMed]. HIV_0328-041014.


4. Synthesis and Structure-activity Analysis of Diphenylpyrazolodiazene Inhibitors of the HIV-1 Nef Virulence Factor. Iyer, P.C., J. Zhao, L.A. Emert-Sedlak, K.K. Moore, T.E. Smithgall, and B.W. Day. Bioorganic & Medicinal Chemistry Letters, 2014. 24(7): p. 1702-1706. PMID[24650642].

[PubMed]. HIV_0328-041014.


5. A Novel Cell-based High-throughput Screen for Inhibitors of HIV-1 Gene Expression and Budding Identifies the Cardiac Glycosides. Laird, G.M., E.E. Eisele, S.A. Rabi, D. Nikolaeva, and R.F. Siliciano. The Journal of Antimicrobial Chemotherapy, 2014. 69(4): p. 988-994. PMID[24275119].

[PubMed]. HIV_0328-041014.


6. EFdA, a Reverse Transcriptase Inhibitor, Potently Blocks HIV-1 Ex Vivo Infection of Langerhans Cells within Epithelium. Matsuzawa, T., T. Kawamura, Y. Ogawa, K. Maeda, H. Nakata, K. Moriishi, Y. Koyanagi, H. Gatanaga, S. Shimada, and H. Mitsuya. The Journal of Investigative Dermatology, 2014. 134(4): p. 1158-1161. PMID[24384694].

[PubMed]. HIV_0328-041014.


7. Design of Antiviral Stapled Peptides Containing a Biphenyl Cross-linker. Muppidi, A., H. Zhang, F. Curreli, N. Li, A.K. Debnath, and Q. Lin. Bioorganic & Medicinal Chemistry Letters, 2014. 24(7): p. 1748-1751. PMID[24613163].

[PubMed]. HIV_0328-041014.


8. The DiPPro Approach: Synthesis, Hydrolysis, and Antiviral Activity of Lipophilic d4T Diphosphate Prodrugs. Schulz, T., J. Balzarini, and C. Meier. ChemMedChem, 2014. 9(4): p. 762-775. PMID[24616176].

[PubMed]. HIV_0328-041014.


9. Synergistic Activity Profile of Carbosilane Dendrimer G2-STE16 in Combination with Other Dendrimers and Antiretrovirals as Topical anti-HIV-1 Microbicide. Sepulveda-Crespo, D., R. Lorente, M. Leal, R. Gomez, F.J. De la Mata, J.L. Jimenez, and M.A. Munoz-Fernandez. Nanomedicine, 2014. 10(3): p. 609-618. PMID[24135563].

[PubMed]. HIV_0328-041014.


10. Competitive Fitness Assays Indicate That the E138A Substitution in HIV-1 Reverse Transcriptase Decreases in Vitro Susceptibility to Emtricitabine. Sluis-Cremer, N., K.D. Huber, C.J. Brumme, and P.R. Harrigan. Antimicrobial Agents and Chemotherapy, 2014. 58(4): p. 2430-2433. PMID[24419343].

[PubMed]. HIV_0328-041014.


11. Anti-HIV-1 Activity of Trim 37. Tabah, A.A., K. Tardif, and L.M. Mansky. Journal of General Virology, 2014. 95(Pt 4): p. 960-967. PMID[24317724].

[PubMed]. HIV_0328-041014.


12. Characterization of VRC01, a Potent and Broadly Neutralizing anti-HIV MAb, Produced in Transiently and Stably Transformed Tobacco. Teh, A.Y., D. Maresch, K. Klein, and J.K. Ma. Plant Biotechnology Journal, 2014. 12(3): p. 300-311. PMID[24256218].

[PubMed]. HIV_0328-041014.


13. Fused Heterocyclic Compounds Bearing Bridgehead Nitrogen as Potent HIV-1 NNRTIs. Part 1: Design, Synthesis and Biological Evaluation of Novel 5,7-Disubstituted pyrazolo[1,5-a]pyrimidine Derivatives. Tian, Y., D. Du, D. Rai, L. Wang, H. Liu, P. Zhan, E. De Clercq, C. Pannecouque, and X. Liu. Bioorganic & Medicinal Chemistry, 2014. 22(7): p. 2052-2059. PMID[24631361].

[PubMed]. HIV_0328-041014.


14. A Multivalent Inhibitor of the DC-SIGN Dependent Uptake of HIV-1 and Dengue Virus. Varga, N., I. Sutkeviciute, R. Ribeiro-Viana, A. Berzi, R. Ramdasi, A. Daghetti, G. Vettoretti, A. Amara, M. Clerici, J. Rojo, F. Fieschi, and A. Bernardi. Biomaterials, 2014. 35(13): p. 4175-4184. PMID[24508075].

[PubMed]. HIV_0328-041014.


15. Discovery of Nitropyridine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors via a Structure-based Core Refining Approach. Wang, J., P. Zhan, Z. Li, H. Liu, E. De Clercq, C. Pannecouque, and X. Liu. European Journal of Medicinal Chemistry, 2014. 76: p. 531-538. PMID[24602795].

[PubMed]. HIV_0328-041014.


16. A Novel Laccase with Inhibitory Activity Towards HIV-I Reverse Transcriptase and Antiproliferative Effects on Tumor Cells from the Fermentation Broth of Mushroom Pleurotus cornucopiae. Wu, X., C. Huang, Q. Chen, H. Wang, and J. Zhang. Biomedical Chromatography, 2014. 28(4): p. 548-553. PMID[24136666].

[PubMed]. HIV_0328-041014.

ISI Web of Knowledge Citations

17. Pungent and Bitter, Cytotoxic and Antiviral Terpenoids from Some Bryophytes and Inedible Fungi. Asakawa, Y., F. Nagashima, T. Hashimoto, M. Toyota, A. Ludwiczuk, I. Komala, T. Ito, and Y. Yagi. Natural Product Communications, 2014. 9(3): p. 409-417. ISI[00331986600032].

[WOS]. HIV_0328-041014.


18. Antiplasmodial, HIV-1 Reverse Transcriptase Inhibitory and Cytotoxicity Properties of Centratherum punctatum Cass. and It's Fractions. Chukwujekwu, J.C., A.R. Ndhlala, C.A. de Kock, P.J. Smith, and J. Van Staden. South African Journal of Botany, 2014. 90: p. 17-19. ISI[000331672400002].

[WOS]. HIV_0328-041014.


19. Design, Synthesis, and Biological Evaluation of Novel Piperidine-4-carboxamide Derivatives as Potent CCR5 Inhibitors. Hu, S.W., Q. Gu, Z.L. Wang, Z.Y. Weng, Y.R. Cai, X.W. Dong, Y.Z. Hu, T. Liu, and X. Xie. European Journal of Medicinal Chemistry, 2014. 71: p. 259-266. ISI[000331496100025].

[WOS]. HIV_0328-041014.


20. Macromolecular Prodrugs for Controlled Delivery of Ribavirin. Kryger, M.B.L., A.A.A. Smith, B.M. Wohl, and A.N. Zelikin. Macromolecular Bioscience, 2014. 14(2): p. 173-185. ISI[000331957700003].

[WOS]. HIV_0328-041014.


21. Stereospecific 3+2 Cycloaddition of 1,2-Cyclopropanated Sugars and Ketones Catalyzed by SnCl4: An Efficient Synthesis of Multi-substituted Perhydrofuro[2,3-b]furans and Perhydrofuro[2,3-b]pyrans. Ma, X.F., J.C. Zhang, Q. Tang, J. Ke, W. Zou, and H.W. Shao. Chemical Communications, 2014. 50(26): p. 3505-3508. ISI[000332453600028].

[WOS]. HIV_0328-041014.


22. A Facile Synthesis of (Z)-5-(Substituted)-2-(methylthio)thiazol-4(5H)-one Using Microwave Irradiation and Conventional Method. Pansare, D.N. and D.B. Shinde. Tetrahedron Letters, 2014. 55(5): p. 1107-1110. ISI[000331505900033].

[WOS]. HIV_0328-041014.


23. Synthesis and Antiviral Evaluation of Novel 2',2'-Difluoro 5'-norcarbocyclic phosphonic acid nucleosides as Antiviral Agents. Shen, G.H. and J.H. Hong. Nucleosides Nucleotides & Nucleic Acids, 2014. 33(1): p. 1-17. ISI[000332060200001].

[WOS]. HIV_0328-041014.


24. Copper-promoted Reductive Homocoupling of Quasi-aromatic Iron(II) Clathrochelates: Boosting the Inhibitory Activity in a Transcription Assay. Varzatskii, O.A., V.V. Novikov, S.V. Shulga, A.S. Belov, A.V. Vologzhanina, V.V. Negrutska, I.Y. Dubey, Y.N. Bubnov, and Y.Z. Voloshin. Chemical Communications, 2014. 50(24): p. 3166-3168. ISI[000332115400009].

[WOS]. HIV_0328-041014.

Patent Citations

25. Cyclotide-based CXCR4 Antagonists with anti-HIV Activity. Camarero, J.A., T.L. Aboye, N. Neamati, and H. Ha. Patent. 2014. 2013-US31775 2014046732: 66pp.

[Patent]. HIV_0328-041014.


26. A Virucidal Small Molecule Comprising PD 404,182 and Uses Thereof for Inactivating Enveloped DNA Virus Particles. Chen, Z., K. Chockalingam, A.M. Chamoun-Emanuelli, R. Simeon, M. Bobardt, and P. Gallay. Patent. 2014. 2013-US59103 2014040087: 93pp.

[Patent]. HIV_0328-041014.


27. Method for Treatment of Disease Caused or Aggravated by Microorganisms or Relieving Symptoms Thereof by Administering a Barrier-forming Compn. Contg. An Antimicrobial to a Surface. Ghannoum, A.M. and B.V. Sokol. Patent. 2014. 2013-14063185 20140051731: 64pp.

[Patent]. HIV_0328-041014.


28. Heterocyclyl Carboxamides for Treating Viral Diseases. Huberman, E. Patent. 2014. 2013-US57585 2014036443: 61pp.

[Patent]. HIV_0328-041014.


29. Preparation of Therapeutic Hydroxypyridinones, Hydroxypyrimidinones and Hydroxypyridazinones as Antiviral Agents. Lavoie, E.J., J.D. Bauman, A. Parhi, H.Y. Sagong, D. Patel, E. Arnold, K. Das, and S.K. Vijayan. Patent. 2014. 2013-US59287 2014043252: 142pp.

[Patent]. HIV_0328-041014.


30. Preparation of Amino Acid Amides Containing a Morpholine Residue as HIV Protease Inhibitors. McCauley, J.A., S. Crane, C. Beaulieu, D.J. Bennett, C.J. Bungard, R.K. Chang, T.J. Greshock, L. Hao, K. Holloway, J.J. Manikowski, D. McKay, C. Molinaro, O.M. Moradei, P.G. Nantermet, C. Nadeau, T. Satyanarayana, W. Shipe, S.K. Singh, V.L. Truong, S. Vijayasaradhi, P.D. Williams, and C.M. Wiscount. Patent. 2014. 2013-US58724 2014043019: 237pp.

[Patent]. HIV_0328-041014.


31. Preparation of Alkylene-bridged (S)-2-[7-(3,4-Dihydro-2H-benzo[b][1,4]oxazin-6-yl)- or 7-(Piperidin-1-yl)-2-(biphenyl-3-yl)pyrazolo[1,5-a]pyrimidin-6-yl]-2-(tert-butoxy)acetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication. Naidu, B.N., M. Patel, S. D'Andrea, Z.B. Zheng, T.P. Connolly, D.R. Langley, K. Peese, Z. Wang, M.A. Walker, and J.F. Kadow. Patent. 2014. 2013-US54532 2014028384: 263pp.

[Patent]. HIV_0328-041014.


32. Preparation of Guanidine and Biguanidine Derivatives as Antiviral and Antimicrobial Agents. Shetty, B.V. Patent. 2014. 2013-14022433 20140073631: 121pp.

[Patent]. HIV_0328-041014.


33. Tris(Hetero)arylpyrazoles as Antiviral Agents and Their Preparation and Use in the Treatment of Retroviral Infection. Wildum, S., B. Klenke, and A. Wendt. Patent. 2014. 2013-EP67201 2014027112: 115pp.

[Patent]. HIV_0328-041014.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024